To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05486000

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05486000
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05486000. Allocation not applicable; no masking; primary purpose treatment. Start 2022-08 (anticipated); primary completion 2026-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure
Condition
Left Heart Failure
Intervention (Device)
Atrial shunt implant system
Lead sponsor
Morningside (Nantong) Medical Co.,Ltd (class: other)
Collaborator
Xiamen Cardiovascular Hospital, Xiamen University (class: other)

Record details

Record id
cardio:ct-nct05486000
Content hash
37f327eb15f18da753adb750f470594efb90c434b14f1509478dfa652806dd56